Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany (vol 17, e0278460, 2022)

被引：0
|
作者：
Schwarz, Florian [1 ]
Arefian, Habibollah [1 ]
Hartmann, Michael [1 ]
Runnebaum, Ingo [1 ]
机构：
[1] Canc Ctr Cent Germany, Jena, Germany
来源：
PLOS ONE | 2024年 / 19卷 / 05期
关键词：
D O I：
10.1371/journal.pone.0303776
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The effectiveness of simultaneous oncoplastic breast surgery in patients with locally advanced breast cancer
    Emiroglu, Mustafa
    Sert, Ismail
    Karaali, Cem
    Aksoy, Suleyman Ozkan
    Ugurlu, Levent
    Aydin, Cengiz
    BREAST CANCER, 2016, 23 (03) : 463 - 470
  • [22] Cost-effectiveness analysis of docetaxel versus other regimens in the adjuvant therapy of early and locally advanced breast cancer in Poland
    Walczak, J.
    Pawlik, D.
    Wojcik, R.
    Kaczor, M.
    Lis, J.
    Nogas, G.
    VALUE IN HEALTH, 2007, 10 (03) : A127 - A127
  • [23] Cost-Effectiveness Analysis: Selective Use of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
    Mueller, Andrew N. N.
    Torgersen, Zachary
    Shashidharan, Maniamparampil
    Ternent, Charles A. A.
    DISEASES OF THE COLON & RECTUM, 2023, 66 (07) : 946 - 956
  • [24] Short-term locally advanced gastric cancer management: A cost-effectiveness analysis
    Prasath, Vishnu
    Quinn, Patrick L.
    Arjani, Simran
    Li, Sharon
    Oliver, Joseph B.
    Mahmoud, Omar Mee
    Jaloudi, Mohammed
    Hajifathalian, Kaveh
    Chokshi, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey
    Sendur, M. A. N.
    Cakar, B.
    Hizal, M.
    Eraslan, E.
    Aksoy, S.
    Paydas, S.
    Demir, N.
    Sen, F.
    Bulut, G.
    Oruc, K.
    Uluc, B. Oyan
    Ozdemir, N.
    Sakin, A.
    Erdem, D.
    Ozkan, M.
    Disel, U.
    Ekinci, F.
    Okten, I. N.
    Ozer, L.
    Gokmen, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S74 - S74
  • [26] Cost-Effectiveness of Gemcitabine Plus Cisplatin and Intensity Modulated Radiation Therapy for Patients With Locally Advanced Cervical Cancer
    Carmona, R.
    Green, G.
    Eren, A. A.
    Eren, M. F.
    Murphy, J. D.
    Mell, L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E361 - E361
  • [27] Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer
    Lee Cheng Phua
    Soo Chin Lee
    Kwong Ng
    Mohamed Ismail Abdul Aziz
    BMC Health Services Research, 20
  • [28] Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer
    Mamiya, H.
    Tahara, R. K.
    Tolaney, S. M.
    Choudhry, N. K.
    Najafzadeh, M.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1825 - 1831
  • [29] Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer
    Phua, Lee Cheng
    Lee, Soo Chin
    Ng, Kwong
    Abdul Aziz, Mohamed Ismail
    BMC HEALTH SERVICES RESEARCH, 2020, 20 (01)
  • [30] Cost-effectiveness and safety of palbociclib and everolimus for treating advanced and recurrent breast cancer
    Kimura, M.
    Usami, E.
    Yoshimura, T.
    PHARMAZIE, 2019, 74 (12): : 763 - 766
12345